Sign up to save your podcasts
Or
Share Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
CME credits: 0.25
Valid until: 21-11-2025
Claim your CME credit at https://reachmd.com/programs/cme/optimizing-outcomes-in-patients-with-igan-novel-therapies-and-evolving-guidelines/26627/
Given that IgA nephropathy is a leading cause of kidney failure, early diagnosis and treatment are essential. In the landscape of the many evolving treatment guidelines, how can nephrologists apply emerging evidence and utilize newer therapies to achieve proteinuria remission and maintain eGFR to improve the outcomes of their patients? Hear the experts answer these questions by reviewing a real-world clinical patient case.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 21-11-2025
Claim your CME credit at https://reachmd.com/programs/cme/optimizing-outcomes-in-patients-with-igan-novel-therapies-and-evolving-guidelines/26627/
Given that IgA nephropathy is a leading cause of kidney failure, early diagnosis and treatment are essential. In the landscape of the many evolving treatment guidelines, how can nephrologists apply emerging evidence and utilize newer therapies to achieve proteinuria remission and maintain eGFR to improve the outcomes of their patients? Hear the experts answer these questions by reviewing a real-world clinical patient case.
=